Scott M. Lippman
0000-0002-1643-4124
Publication & Citation Trends
Publications
0 total
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations
Cited by 3
Semantic Scholar
Liquid Biopsy Differentiation of Pancreatic Cancer From Non‐Cancerous Pancreatic Disease Using Dielectrophoresis‐Recovered Nanoparticles Carrying Cell‐Free DNA and Protein Biomarkers
Cited by 0
Semantic Scholar
Genome-wide CRISPR screening reveals a PKA-driven resistance mechanism to metformin for oral cancer prevention that can be exploited by combination with NSAIDs.
Cited by 1
Semantic Scholar
Oncogenic H-RAS induces metformin resistance in head and neck cancer by promoting glycolytic metabolism.
Cited by 3
Semantic Scholar
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer
Cited by 14
Semantic Scholar
Reply to: Optimizing DeepHRD Interpretability for Enhanced Clinical Decision Making.
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(187)
Cancer Genomics and Diagnostics
(127)
Retinoids in leukemia and cellular processes
(109)
Head and Neck Cancer Studies
(107)
Estrogen and related hormone effects
(77)
Affiliations
Inje University
Northwestern University
Ontario Institute for Cancer Research
Hiroshima University
University of Southern California